Influence of prolonged treatment with omalizumab on the development of solid epithelial cancer in patients with atopic asthma and chronic idiopathic urticaria: A systematic review and meta‐analysis
| dc.contributor.author | Johnston, Amy | |
| dc.contributor.author | Smith, Christine | |
| dc.contributor.author | Zheng, Carine | |
| dc.contributor.author | Aaron, Shawn D | |
| dc.contributor.author | Kelly, Shannon E | |
| dc.contributor.author | Skidmore, Becky | |
| dc.contributor.author | Wells, George A. | |
| dc.date.accessioned | 2020-03-31T17:11:21Z | |
| dc.date.available | 2020-07-03T09:00:08Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | We investigated whether prolonged treatment with omalizumab influences development or progression of solid epithelial cancer in patients with atopic asthma or chronic idiopathic urticaria. | en_US |
| dc.embargo.terms | 2020-07-01 | |
| dc.identifier.doi | 10.1111/cea.13457 | en_US |
| dc.identifier.issn | 0954-7894 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10393/40287 | |
| dc.identifier.uri | https://doi.org/10.20381/ruor-24520 | |
| dc.language.iso | en | en_US |
| dc.subject | anti-IgE | en_US |
| dc.subject | asthma | en_US |
| dc.subject | atopy | en_US |
| dc.subject | cancer | en_US |
| dc.subject | systematic review | en_US |
| dc.subject | urticaria | en_US |
| dc.title | Influence of prolonged treatment with omalizumab on the development of solid epithelial cancer in patients with atopic asthma and chronic idiopathic urticaria: A systematic review and meta‐analysis | en_US |
| dc.type | Article | en_US |
